Bal Pharma Limited(IN:BALPHARMA)
₹90.10+1.87 (+2.12%)
IN:BALPHARMA
Bal Pharma Limited financials statements
₹90.10
At close:+1.87 (+2.12%)
Want to see IN:BALPHARMA full AI Analyst Report?
Bal Pharma Limited (BALPHARMA) Income Statement
0 Followers
Bal Pharma Limited Income Statement
Last quarter (Q1 2027), Bal Pharma Limited's total revenue was ₹886.16M, an increase of 34.53% from the same quarter last year. In Q1, Bal Pharma Limited's net income was ₹11.23M. See Bal Pharma Limited’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| ₹ 3.12B | ₹ 3.03B | ₹ 3.39B | ₹ 3.04B | ₹ 2.81B | |
| ₹ 761.52M | ₹ 730.18M | ₹ 770.20M | ₹ 1.25B | ₹ 1.11B | |
| ₹ 553.28M | ₹ 396.01M | ₹ 396.65M | ₹ 1.08B | ₹ 967.88M | |
| Depreciation and Amortization | ₹ 110.79M | ₹ 97.71M | ₹ 100.71M | ₹ 91.28M | ₹ 90.40M |
| ₹ 338.31M | ₹ 317.63M | ₹ 320.23M | ₹ 245.00M | ₹ 239.71M | |
| ₹ 208.24M | ₹ 197.89M | ₹ 214.57M | ₹ 177.23M | ₹ 149.18M | |
| ₹ -148.90M | ₹ -146.51M | ₹ -127.28M | ₹ -127.97M | ₹ -57.35M | |
| ₹ 59.34M | ₹ 51.38M | ₹ 90.47M | ₹ 47.48M | ₹ 91.83M | |
| ₹ 62.84M | ₹ 72.15M | ₹ 73.92M | ₹ 25.72M | ₹ 56.12M | |
| Per Share Metrics | |||||
| Basic EPS | ₹ 3.95 | ₹ 4.56 | ₹ 4.70 | ₹ 1.64 | ₹ 3.79 |
| Diluted EPS | ₹ 3.95 | ₹ 4.56 | ₹ 4.68 | ₹ 1.64 | ₹ 3.79 |
| Weighted Average Shares Outstanding | 15.91M | 14.58M | 14.96M | 15.69M | 14.82M |
| Weighted Average Shares Outstanding (Diluted) | 15.91M | 14.58M | 15.80M | 15.69M | 15.14M |
Currency in INR
